ARTL
Artelo Biosciences·NASDAQ
--
--(--)
--
--(--)
ARTL fundamentals
Artelo Biosciences (ARTL) released its earnings on Aug 13, 2025: revenue was 0 (YoY --), met estimates; EPS was -16.83 (YoY -24.67%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-16.83
-24.67%
Report date
Aug 13, 2025
EPS
Actual | -72.9 | -59.4 | -37.8 | -29.7 | -27 | -21.6 | -15.66 | -14.76 | -13.68 | -10.08 | -14.94 | -17.82 | -14.04 | -13.5 | -6.3 | -21.06 | -12.96 | -16.83 | |||
Forecast | -108 | -97.2 | -27 | -31.05 | -18.9 | -14.85 | -15.3 | -15.9 | -19.8 | -13.95 | -11.64 | -10.02 | -17.64 | -14.28 | -14.265 | -7.86 | -2.3994 | -12.57 | |||
Surprise | 0.00% | 0.00% | 0.00% | +32.50% | +38.89% | -40.00% | +4.35% | -42.86% | -45.45% | -2.35% | +7.17% | +30.91% | +27.74% | -28.35% | -77.84% | +20.41% | +5.46% | +55.84% | -167.94% | -440.14% | -33.89% |
Revenue
Actual | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -- | 0 | 0 |
Forecast | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What factors drove the changes in Artelo Biosciences's revenue and profit?What is the market's earnings forecast for Artelo Biosciences next quarter?What is the revenue and EPS growth rate for Artelo Biosciences year over year?What guidance did Artelo Biosciences's management provide for the next earnings period?What is Artelo Biosciences's gross profit margin?What were the key takeaways from Artelo Biosciences’s earnings call?What does Artelo Biosciences do and what are its main business segments?What were the key takeaways from Artelo Biosciences's earnings call?
